Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H10F6N2O3 |
| Molecular Weight | 380.2419 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1NC(=O)NC2=CC(=CC=C2O)C(F)(F)F)C(F)(F)F
InChI
InChIKey=NJFVQMRYJZHGME-UHFFFAOYSA-N
InChI=1S/C15H10F6N2O3/c16-14(17,18)7-1-3-11(24)9(5-7)22-13(26)23-10-6-8(15(19,20)21)2-4-12(10)25/h1-6,24-25H,(H2,22,23,26)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25232191Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27199074 | https://www.ncbi.nlm.nih.gov/pubmed/25809254 | https://www.ncbi.nlm.nih.gov/pubmed/25809253 | https://www.ncbi.nlm.nih.gov/pubmed/21135701
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25232191
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27199074 | https://www.ncbi.nlm.nih.gov/pubmed/25809254 | https://www.ncbi.nlm.nih.gov/pubmed/25809253 | https://www.ncbi.nlm.nih.gov/pubmed/21135701
NS-1643 is an activator of the human ether-a-go-go related gene (ERG1, KCNH2, hERG) KV11.1 channel. NS-1643 shows significantly increase both steady-state and peak tail currents of hERG channels but exhibits only a trivial effect on Kv4.3 and Kv1.5 channels. Causes a significant reduction in action potential duration in patch clamp assays in Xenopus oocytes, HEK293 cells, and guinea pig cardiomyocytes that can be reversed by the addition of E-4031, a specific blocker of hERG channels. Also shown to activate IKr channel in cardiomyocytes and increase post-repolarization refractory time thereby alleviating hyper-excitability and producing antiarrhythmic effects. NS-1643 can also restore IKr reduced by down-regulation of IKr expression. NS-1643 also activates the KV11.2 (ERG2, KCNH6) channel, but evokes a distinctly different response from that of KV11.1. NS-1643 is commonly used for Biochemicals applications.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL240 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25809254 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of the small molecule HERG activator NS1643 on Kv11.3 channels. | 2012 |
|
| Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels. | 2010-10 |
|
| Loss of functional K+ channels encoded by ether-à-go-go-related genes in mouse myometrium prior to labour onset. | 2009-05-15 |
|
| Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells. | 2008-12 |
|
| Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. | 2008-07-01 |
|
| Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243). | 2008-06 |
|
| Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart. | 2008-05 |
|
| Erg K+ channels modulate contractile activity in the bovine epididymal duct. | 2008-03 |
|
| Voltage-dependent Ca2+ channels, not ryanodine receptors, activate Ca2+-dependent BK potassium channels in human retinal pigment epithelial cells. | 2008 |
|
| Activation of ERG2 potassium channels by the diphenylurea NS1643. | 2007-08 |
|
| Mechanism of action of a novel human ether-a-go-go-related gene channel activator. | 2006-02 |
|
| Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). | 2006-01 |
|
| Modulation of the Ca(2+)-dependent K+ channel, hslo, by the substituted diphenylurea NS 1608, paxilline and internal Ca2+. | 1996 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21135701
LQT1 rabbits were treated with NS1643 (1.5 mg/kg/min) or vehicle (50% polyethylene glycol 400/50% isotonic glucose 5%) for 45 minutes.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25809254
Transfected hEK cells were used for activity evaluation by whole-cell voltage-clamp methods. The coverslips were placed in a 2 cc chamber, which was superfused at a rate of 2 mL/min at room temperature. The pipette solution contained KCl 10 mM, K-aspartate 110 mM, MgCl2 5 mM, Na2 ATP 5 mM, EGTA 10 mM, HEPES 5 mM, and CaCl2 1 mM, corrected to pH 7.2 with KOH. The extracellular solution contained NaCl 140 mM, KCl 5.4 mM, CaCl2 1 mM, MgCl2 1 mM, HEPES 5 mM, and glucose 5.5 mM, corrected to pH 7.4 with NaOH. For IKr measurements, the whole cell configuration of the patch-clamp method was used. The series resistance measured in the solution was <7 MU. Data were sampled at 1 kHz. The holding potential was -80 mV. All tail currents reported in this article represent dofetilide-sensitive currents. The NS1643 (Tocris Bioscience, Ellisville, MO) was dissolved in DMSO (30 mM) first and then diluted into the extracellular solution. All the experiments were performed at room temperature. The data was sampled at 2 kHz and analyzed with the software CLAMPFIT (Axon Instruments, Molecular Devices, Eugene, OR).
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
448895-37-2
Created by
admin on Mon Mar 31 22:49:33 GMT 2025 , Edited by admin on Mon Mar 31 22:49:33 GMT 2025
|
PRIMARY | |||
|
DTXSID00436481
Created by
admin on Mon Mar 31 22:49:33 GMT 2025 , Edited by admin on Mon Mar 31 22:49:33 GMT 2025
|
PRIMARY | |||
|
10177784
Created by
admin on Mon Mar 31 22:49:33 GMT 2025 , Edited by admin on Mon Mar 31 22:49:33 GMT 2025
|
PRIMARY | |||
|
0I579CNG0I
Created by
admin on Mon Mar 31 22:49:33 GMT 2025 , Edited by admin on Mon Mar 31 22:49:33 GMT 2025
|
PRIMARY |
ACTIVE MOIETY